Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Auris shares are crushed as tinnitus drug fails PhIII test
Auris shares are crushed as tinnitus drug fails PhIII test
Auris shares are crushed as tinnitus drug fails PhIII test
Submitted by
admin
on August 18, 2016 - 9:01am
Source:
Endpoints
News Tags:
Auris
tinnitus
clinical trials
Keyzilen
AM-101
Headline:
Auris shares are crushed as tinnitus drug fails PhIII test
Do Not Allow Advertisers to Use My Personal information
